Clinical trial
A Randomized, Double-blind, Comparison of the Efficacy, Safety, and Relapse of Electroconvulsive Therapy (ECT) to ECT Plus Agomelatine in the Treatment of Patients With Major Depressive Disorder
NCT04181567 is registered in ClinicalTrials.gov with Kaohsiung Kai-Suan Psychiatric Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Comparison of the Efficacy, Safety, and Relapse of Electroconvulsive Therapy (ECT) to ECT Plus Agomelatine in the Treatment of Patients With Major Depressive Disorder
- Lead sponsor
- Kaohsiung Kai-Suan Psychiatric Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 3, 2014
- Completion date
- November 22, 2019
- Enrollment
- 97 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.